Cause of death: Suicide

Journal of Molecular and Cellular Cardiology

Volumn 40, Issue 4, 2006, Pages 425-437

  Kajstura, Jan ^a   Bolli, Roberto ^a   Sonnenblick, Edmund H ^a   Anversa, Piero ^a   Leri, Annarosa ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; REACTIVE OXYGEN METABOLITE; STREPTOZOCIN;

APOPTOSIS; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; DEREGULATION; DIABETES MELLITUS; DNA DAMAGE; HEART FAILURE; HEART MUSCLE; HEART VENTRICLE PERFORMANCE; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; TELOMERE;

EID: 33645079929     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2005.12.013     Document Type: Article

References (223)

1. R.E. Ellis, J. Yuan, and H.R. Horvitz Mechanisms and functions of cell death Annu. Rev. Cell Biol. 7 1991 663 698
2. M.D. Jacobson, M. Weil, and M.C. Raff Programmed cell death in animal development Cell 88 1997 347 354
3. N.N. Danial, and S.J. Korsmeyer Cell death: critical control points Cell 116 2004 205 219
4. P. Cashio, T.V. Lee, and A. Bergmann Genetic control of programmed cell death in Drosophila melanogaster Semin. Cell Dev. Biol. 16 2005 225 235
5. M. Leist, and M. Jaattela Four deaths and a funeral: from caspases to alternative mechanisms Nat. Rev. Mol. Cell Biol. 2 2001 589 598
6. S.H. Kaufmann, and M.O. Hengartner Programmed cell death: alive and well in the new millennium Trends Cell Biol. 11 2001 526 534
7. K. Cain Chemical-induced apoptosis: formation of the Apaf-1 apoptosome Drug Metab. Rev. 35 2003 337 363
8. C. Nakanishi, and M. Toi Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs Nat. Rev. Cancer 5 2005 297 309
9. A. Jurisicova, and B.M. Acton Deadly decisions: the role of genes regulating programmed cell death in human preimplantation embryo development Reproduction 128 2004 281 291
10. D.R. Hipfner, and S.M. Cohen Connecting proliferation and apoptosis in development and disease Nat. Rev. Mol. Cell Biol. 5 2004 805 815
11. R.H. Gomer Not being the wrong size Nat. Rev. Mol. Cell Biol. 2 2001 48 54
12. M. Kim, and N. Sinha Regulating shapes and sizes Dev. Cell 4 2003 441 442
13. C.J. Potter, and T. Xu Mechanisms of size control Curr. Opin. Genet. Dev. 11 2001 279 286
14. E.L. Rawlins, and A.P. Jarman Mitogens match cell numbers to local demand Trends Cell Biol. 11 2001 277 278
15. C. Borner The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions Mol. Immunol. 39 2003 615 647
16. S. Willis, C.L. Day, M.G. Hinds, and D.C. Huang The Bcl-2-regulated apoptotic pathway J. Cell Sci. 116 2003 4053 4056
17. X. Guirao, and S.F. Lowry Biologic control of injury and inflammation: much more than too little or too late World J. Surg. 20 1996 437 446
18. P. Anversa, and J. Kajstura Myocyte cell death in the diseased heart Circ. Res. 82 1998 1231 1233
19. T.M. Lotti, C. Comacchi, and I. Ghersetich Cutaneous necrotizing vasculitis: relation to systemic disease Adv. Exp. Med. Biol. 455 1999 115 125
20. S. Guerra, A. Leri, X. Wang, N. Finato, C. Di Loreto, and C.A. Beltrami Myocyte death in the failing human heart is gender dependent Circ. Res. 85 1999 856 866
21. I. Uthman Pharmacological therapy of vasculitis: an update Curr. Opin. Pharmacol. 4 2004 117 182
22. V. Gangji, and J.P. Hauzer Treatment of osteonecrosis of the femoral head with autologous implantation of bone marrow stem cells. Surgical techniques J. Bone Joint Surg. Am. 87 2005 106 112
23. G. Majno, and I. Joris Apoptosis, oncosis, and necrosis. An overview of cell death Am. J. Pathol. 146 1995 3 15
24. B.F. Trump, I.K. Berezesky, S.H. Chang, and P.C. Phelps The pathways of cell death: oncosis, apoptosis, and necrosis Toxicol. Pathol. 25 1997 82 88
25. S. Van Cruchten, and W. Van Den Broeck Morphological and biochemical aspects of apoptosis, oncosis and necrosis Anat. Histol. Embryol. 31 2002 214 223
26. P. Anversa, J. Kajstura, and G. Olivetti Myocyte death in heart failure Curr. Opin. Cardiol. 11 1996 245 251
27. F. von Recklinghausen Untersuchungen über Rachitis and Osteomalacie 1910 Verlag Gustav Fisher Jena
28. A. Elsasser, K. Suzuki, and J. Schaper Unresolved issues regarding the role of apoptosis in the pathogenesis of ischemic injury and heart failure J. Mol. Cell. Cardiol. 32 2000 711 724
29. H. Jaeschke, and J.J. Lemasters Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury Gastroenterology 125 2003 1246 1257
30. S. Van Cruchten, and W. Van Den Broeck Morphological and biochemical aspects of apoptosis, oncosis and necrosis Anat. Histol. Embryol. 31 2002 214 223
31. X. Liu, T. Van Vleet, and R.G. Schnellmann The role of calpain in oncotic cell death Annu. Rev. Pharmacol. Toxicol. 44 2004 349 370
32. D.J. Klionsky, and S.D. Emr Autophagy as a regulated pathway of cellular degradation Science 290 2000 1717 1721
33. Y. Ohsumi Molecular dissection of autophagy: two ubiquitin-like systems Nat. Rev. Mol. Cell Biol. 2 2001 211 216
34. E.H. Baehrecke Autophagy: dual roles in life and death? Nat. Rev. Mol. Cell Biol. 6 2005 505 510
35. V. Jesenberger, and S. Jentsch Deadly encounter: ubiquitin meets apoptosis Nat. Rev. Mol. Cell Biol. 3 2002 112 121
36. D.S. Goodsell The molecular perspective: double-stranded DNA breaks Oncologist 10 2005 361 362
37. V.V. Didenko, and P.J. Hornsby Presence of double-strand breaks with single-base 3′ overhangs in cells undergoing apoptosis but not necrosis J. Cell Biol. 135 1996 1369 1376
38. P.J. Hornsby, and V.V. Didenko In situ DNA litigation as a method for labeling apoptotic cells in tissue sections. An overview Methods Mol. Biol. 203 2002 133 141
39. V.V. Didenko, J.R. Turnstead, and P.J. Hornsby Biotin-labeled hairpin oligonucleotides: probes to detect double-strand breaks in DNA in apoptotic cells Am. J. Pathol. 152 1998 897 902
40. B. Conradt With a little help from your friends: cells don't die alone Nat. Cell Biol. 4 2002 139 143
41. P. Williamson, and R.A. Schlegel Hide and seek: the secret identity of the phosphatidylserine receptor J. Biol. 3 2004 14
42. J.B. Weitzman The curious world of apoptotic cell clearance J. Biol. 3 2004 13
43. P.F. Shanley The pathology of chronic renal ischemia Semin. Nephrol. 16 1996 21 32
44. Y. Sun, J.Q. Zhang, J. Zhang, and F.J. Ramires Angiotensin II, transforming growth factor-beta l and repair in the infarcted heart J. Mol. Cell. Cardiol. 30 1998 1559 1569
45. C. Morales, G.E. Gonzalez, M. Rodriguez, C.A. Bertolasi, and R.J. Gelpi Histopathologic time course of myocardial infarct in rabbit hearts Cardiovasc. Pathol. 11 2002 339 345
46. G. Kloppel, S. Detlefsen, and B. Feyerabend Fibrosis of the pancreas: the initial tissue damage and the resulting pattern Virchows Arch. 445 2004 1 8
47. J.F. Kerr, A.H. Wyllie, and A.R. Currie Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics Br. J. Cancer 26 1972 239 257
48. J. Searle, D.J. Collins, B. Harmon, and J.F. Kerr The spontaneous occurrence of apoptosis in squamous carcinomas of the uterine cervix Pathology 5 1973 163 169
49. K. Hashimoto Apoptosis in lichen planus and several other dermatoses. Intra-epidermal cell death with filamentous degeneration Acta Derm. Venereol. 56 1976 187 210
50. D. Weedon, J. Searle, and J.F. Kerr Apoptosis. Its nature and implications for dermatopathology Am. J. Dermatopathol. 1 1979 133 144
51. A.H. Wyllie, J.F. Kerr, and A.R. Currie Cell death: the significance of apoptosis Int. Rev. Cytol. 68 1980 251 306
52. R.L. Olson, and M.A. Everett Epidermal apoptosis: cell deletion by phagocytosis J. Cutan. Pathol. 2 1975 53 57
53. A.H. Wyllie, R.G. Morris, A.L. Smith, and D. Dunlop Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis J. Pathol. 142 1984 67 77
54. A.H. Wyllie The biology of cell death in tumours Anticancer Res. 5 1985 131 136
55. D.R. Croft, M.L. Coleman, S. Li, D. Robertson, T. Sullivan, and C.L. Stewart Actin-myosin-based contraction is responsible for apoptotic nuclear disintegration J. Cell Biol. 168 2005 245 255
56. M.L. Coleman, and M.F. Olson Rho GTPase signaling pathways in the morphological changes associated with apoptosis Cell Death Differ. 9 2002 493 504
57. M.L. Coleman, E.A. Sahai, M. Yeo, M. Bosch, A. Dewar, and M.F. Olson Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I Nat. Cell Biol. 3 2001 339 345
58. Beaudouin J, Gerlich D, Daigle N, Eils R, Ellenberg J. Nuclear envelope breakdown proceeds by microtubule-induced tearing of the lamina. 2002; 108: 83-96.
59. B. Burke, and J. Ellenberg Remodelling the walls of the nucleus Nat. Rev. Mol. Cell Biol. 3 2002 487 497
60. J.L. Broers, N.M. Bronnenberg, H.J. Kuijpers, B. Schutte, C.J. Hutchinson, and F.C. Ramaekers Partial cleavage of A-type lamins concurs with their total disintegration from the nuclear lamina during apoptosis Eur. J. Cell Biol. 81 2002 677 691
61. D. Salina, K. Bodoor, D.M. Eckley, T.A. Schroer, J.B. Rattner, and B. Burke Cytoplasmic dynein as a facilitator of nuclear envelope breakdown Cell 108 2002 97 107
62. A. Rosen, and L. Casciola-Rosen Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease Cell Death Differ. 6 1999 6 12
63. B.A. Cocca, A.M. Cline, and M.Z. Radic Blebs and apoptotic bodies are B cell autoantigens J. Immunol. 169 2002 159 166
64. M.C. Raff Size control: the regulation of cell numbers in animal development Cell 86 1996 173 175
65. A. Hidalgo ffrench-Constant C. The control of cell number during central nervous system development in flies and mice Mech. Dev. 120 2003 1311 1325
66. J. Campisi Cellular senescence and apoptosis: how cellular responses might influence aging phenotypes Exp. Gerontol. 38 2003 5 11
67. J.E. Johnson Numb and Numb-like control cell number during vertebrate neurogenesis Trends Neurosci. 26 2003 395 396
68. J. Campisi Cancer and ageing: rival demons? Nat. Rev. Cancer 3 2003 339 349
69. T. Itoh, C. O'Shea, and S. Linn Impaired regulation of tumor suppressor p53 caused by mutations in the Xeroderma pigmentosum DDB2 gene: mutual regulatory interactions between p48(DDB2) and p53 Mol. Cell. Biol. 23 2003 7540 7553
70. A.C. Rego, and C.R. Oliveira Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases Neurochem. Res. 28 2003 1563 1574
71. X. Meng, J.F. Klement, D.A. Leperi, D.E. Birk, T. Sasaki, and R. Timpl Targeted inactivation of murine laminin gamma-2-chain gene recapitulates human junctional epidermolysis bullosa J. Invest. Dermatol. 121 2003 720 731
72. N. Dias, and C. Bailly Drugs targeting mitochondrial functions to control tumor cell growth Biochem. Pharmacol. 70 2005 1 12
73. A. Szewczyk, and L. Wojtczak Mitochondria as a pharmacological target Pharmacol. Rev. 54 2002 101 127
74. T. von Zglinicki Telomeres: influencing the rate of aging Ann. N. Y. Acad. Sci. 854 1998 318 327
75. J. Campisi, S.H. Kim, C.S. Lim, and M. Rubio Cellular senescence, cancer and aging: the telomere connection Exp. Gerontol. 36 2001 1619 1637
76. L. Harrington, and M.O. Robinson Telomere dysfunction: multiple paths to the same end Oncogene 21 2002 592 597
77. S.E. Artandi, and L.D. Attardi Pathways connecting telomeres and p53 in senescence, apoptosis, and cancer Biochem. Biophys. Res. Commun. 331 2005 881 890
78. K. Itahana, J. Campisi, and G.P. Dimri Mechanisms of cellular senescence in human and mouse cells Biogerontology 5 2004 1 10
79. N.E. Sharpless, and R.A. DePinho Telomeres, stem cells, senescence, and cancer J. Clin. Invest. 113 2004 160 168
80. P.G. Pelicci Do tumor-suppressive mechanisms contribute to organism aging by inducing stem cell senescence? J. Clin. Invest. 113 2004 4 7
81. S.E. Artandi, and R.A. DePinho Mice without telomerase: what can they teach us about human cancer? Nat. Med. 6 2000 852 855
82. S.E. Artandi, and R.A. DePinho A critical role for telomeres in suppressing and facilitating carcinogenesis Curr. Opin. Genet. Dev. 10 2000 39 46
83. Campisi J. Cancer and aging: yin, yang, and p53. Sci Aging Knowledge Environ 2002; 2002: pe1.
84. J. Campisi Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors Cell 120 2005 513 522
85. C. Chimenti, J. Kajstura, D. Torella, K. Urbanek, H. Heleniak, and C. Colussi Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure Cir. Res. 93 2003 604 613
86. K. Urbanek, D. Torella, F. Sheikh, A. De Angelis, D. Nurzynska, and F. Silvestri Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure Proc. Natl. Acad. Sci. USA 102 2005 8692 8697
87. A. Frustaci, J. Kajstura, C. Chimenti, I. Jakoniuk, A. Leri, and A. Maseri Myocardial cell death in human diabetes Circ. Res. 87 2000 1123 1132
88. T.M. Hagen Oxidative stress, redox imbalance, and the aging process Antiox Redox Signal 5 2003 503 506
89. R.S. Balaban, S. Nemoto, and T. Finkel Mitochondria, oxidants, and aging Cell 120 2005 483 495
90. C. Twomey, and J.V. McCarthy Pathways of apoptosis and importance in development J. Cell. Mol. Med. 9 2005 345 359
91. R. Kim Unknotting the roles of Bcl-2 and Bcl-xL in cell death Biochem. Biophys. Res. Commun. 333 2005 336 343
92. S. Gupta Molecular mechanisms of apoptosis in the cells of the immune system in human aging Immunol. Rev. 205 2005 114 129
93. J. Perfettini, T. Roumier, and G. Kroemer Mitochondrial fusion and fission in the control of apoptosis Trends Cell Biol. 15 2005 179 183
94. J. Marin-Garcia, and M.J. Goldenthal Heart mitochondria signaling pathways: appraisal of an emerging field J. Mol. Med. 82 2004 565 578
95. D.R. Green, and G. Kroemer The pathophysiology of mitochondrial cell death Science 305 2004 626 629
96. L. Skarka, and B. Ostadal Mitochondrial membrane potential in cardiac myocytes Physiol. Res. 51 2005 425 434
97. J. Henry-Mowatt, C. Dive, J.C. Martinou, and D. James Role of mitochondrial membrane permeabilization in apoptosis and cancer Oncogene 23 2004 2850 2860
98. J. Yang, X. Liu, K. Bhalla, C.N. Kim, A.M. Ibrado, and J. Cai Prevention of apoptosis by Bcl-2; release of cytochrome c from mitochondria blocked Science 275 1997 1129 1132
99. Y. Tsujimoto, and S. Shimizu Bcl-2 family: life-or-death switch FEBS Lett. 466 2000 6 10
100. Y. Tsujimoto Cell death regulation by the Bcl-2 protein family in the mitochondria J. Cell. Physiol. 195 2003 158 167
101. D.G. Breckenridge, and D. Xue Regulation of mitochondrial membrane permeabilization by Bcl-2 family proteins and caspases Curr. Opin. Cell Biol. 16 2004 647 652
102. J. Cesselli, I. Jakoniuk, L. Barlucchi, A.P. Beltrami, T.H. Hintze, and B. Nadal-Ginard Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy Circ. Res. 89 2001 279 286
103. J.M. Adams, and S. Cory Apoptosomes: engines for caspase activation Curr. Opin. Cell Biol. 14 2002 715 720
104. E. Ferraro, M. Corvaro, and F. Cecconi Physiological and pathological roles of Apaf1 and the apoptosome J. Cell. Mol. Med. 7 2003 21 34
105. S.J. Martin, and D.R. Green Protease activation during apoptosis: death by a thousand cuts Cell 82 1995 349 352
106. R.A. Gottlieb, D.L. Gruol, J.Y. Zhu, and R.L. Engler Preconditioning rabbit cardiomyocytes: role of pH, vacuolar proton ATPase, and apoptosis J. Clin. Invest. 97 1996 2391 2398
107. J. Kajstura, W. Cheng, R. Sarangarajan, B. Li, J.A. Nitahara, and S. Chapnick Necrotic and apoptotic myocyte cell death in the aging heart of Fischer 344 rats Am. J. Physiol. 271 1996 H1215 H1228
108. G. Olivetti, F. Quaini, R. Sala, C. Lagrasta, D. Corradi, and E. Bonacina Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart J. Mol. Cell. Cardiol. 28 1996 2005 2016
109. W. Cheng, J. Kajstura, J.A. Nitahara, B. Li, K. Reiss, and Y. Liu Programmed myocyte cell death affects the viable myocardium after infarction in rats Exp. Cell Res. 226 1996 316 327
110. G. Olivetti, R. Abbi, F. Quaini, J. Kajstura, W. Cheng, and J.A. Nitahara Apoptosis in the failing human heart N. Engl. J. Med. 336 1997 1131 1141
111. J. Schaper, A. Elsasser, and S. Kostin The role of cell death in heart failure Circ. Res. 85 1999 867 869
112. A. Elsasser, K. Suzuki, and J. Schaper Unresolved issues regarding the role of apoptosis in the pathogenesis of ischemic injury and heart failure J. Mol. Cell. Cardiol. 32 2000 711 724
113. A. Elsasser, K. Suzuki, S. Lorenz-Meyer, C. Bode, and J. Schaper The role of apoptosis in myocardial ischemia: a critical appraisal Basic Res. Cardiol. 96 2001 219 226
114. P. Anversa, and B. Nadal-Ginard Myocyte renewal and ventricular remodeling Nature 415 2002 240 243
115. B. Nadal-Ginard, J. Kajstura, A. Leri, and P. Anversa Myocyte death, growth, and regeneration in cardiac hypertrophy and failure Circ. Res. 92 2003 139 150
116. A.P. Beltrami, L. Barlucchi, D. Torella, M. Baker, F. Limana, and S. Chimenti Adult cardiac stem cells are multipotent and support myocardial regeneration Cell 114 2003 763 776
117. M.H. Soonpaa, and L.J. Field Survey of studies examining mammalian cardiomyocyte DNA synthesis Circ. Res. 13 83 1998 15 26
118. W.R. MacLellan, and M.D. Schneider Genetic dissection of cardiac growth control pathways Annu. Rev. Physiol. 62 2000 289 319
119. K.R. Chien Stem cells: lost in translation Nature 8 428 2004 607 608
120. S. Dimmeler, A.M. Zeiher, and M.D. Schneider Unchain my heart: the scientific foundations of cardiac repair J. Clin. Invest. 115 2005 572 583
121. A.P. Beltrami, K. Urbanek, J. Kajstura, S.M. Yan, N. Finato, and R. Bussani Evidence that human cardiac myocytes divide after myocardial infarction N. Engl. J. Med. 344 2001 1750 1757
122. A. Leri, L. Barlucchi, F. Limana, A. Deptala, Z. Darzynkiewicz, and T.H. Hintze Telomerase expression and activity are coupled with myocyte proliferation and preservation of telomeric length in the failing heart Proc. Natl. Acad. Sci. USA 98 2001 8626 8631
123. F. Limana, K. Urbanek, S. Chimenti, F. Quaini, A. Leri, and J. Kajstura bcl-2 overexpression promotes myocyte proliferation Proc. Natl. Acad. Sci. USA 99 2002 6257 6262
124. A. Linke, P. Muller, D. Nurzynska, C. Casarsa, D. Torella, and A. Nascimbene Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function Proc. Natl. Acad. Sci. USA 102 2005 8966 8971
125. Y. Liu, E. Cigola, W. Cheng, J. Kajstura, G. Olivetti, and T.H. Hintze Myocyte nuclear mitotic division and programmed myocyte cell death characterized the cardiac myopathy induced by rapid ventricular pacing in dogs Lab. Invest. 73 1995 771 787
126. V.G. Sharov, H.N. Sabbah, H. Shimoyama, A.V. Goussev, M. Lesch, and S. Goldstein Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure Am. J. Pathol. 148 1996 141 149
127. J. Narula, N. Haider, R. Virmani, T.G. DiSalvo, F.D. Kolodgie, and R.J. Hajjar Apoptosis in myocytes in end-stage heart failure N. Engl. J. Med. 335 1996 1182 1189
128. Z. Mallat, A. Tedgui, F. Fontaliran, R. Frank, M. Durigon, and G. Fontaine Evidence of apoptosis in arrhythmogenic right ventricular dysplasia N. Engl. J. Med. 335 1996 1190 1196
129. W.S. Colucci Apoptosis in the heart N. Engl. J. Med. 335 1996 1224 1226
130. H. Hirota, J. Chen, U.A. Betz, K. Rajewsky, Y. Gu, and J. Ross Jr. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress Cell 97 1999 189 198
131. M. Resnicoff, D. Abraham, W. Yutanawiboonchai, H.L. Rotman, J. Kajstura, R. Rubin, P. Zoltick, and R. Baserga The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo Cancer Res. 55 1995 2463 2469
132. D.R. Green Apoptotic pathways: ten minutes to dead Cell 121 2005 671 674
133. V.V. Didenko, and P.J. Hornsby Presence of double-strand breaks with single-base 3′ overhangs in cells undergoing apoptosis but not necrosis J. Cell Biol. 135 1996 1369 1376
134. V.V. Didenko Detection of specific double-strand DNA breaks and apoptosis in situ using T4 DNA ligase Methods Mol. Biol. 203 2003 143 151
135. V.V. Didenko, H. Ngo, and D.S. Bakin Early necrotic DNA degradation: presence of blunt-ended DNA breaks, 3′ and 5′ overhangs in apoptosis, but only 5′ overhangs in early necrosis Am. J. Pathol. 162 2003 1571 1578
136. V.V. Didenko, J.R. Tunstead, and P.J. Hornsby Biotin-labeled hairpin oligonucleotides: probes to detect double-strand breaks in DNA apoptotic cells Am. J. Pathol. 152 1998 897 902
137. F. Fiordaliso, A. Leri, D. Cesselli, F. Limana, B. Safai, and B. Nadal-Ginard Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death Diabetes 50 2001 2363 2375
138. A. Leri, S. Franco, A. Zacheo, L. Barlucchi, S. Chimenti, and F. Limana Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation EMBO J. 22 2003 131 139
139. R.S. Foo, K. Mani, and R.N. Kitsis Death begets failure in the heart J. Clin. Invest. 115 2005 565 571
140. J.L. Pool The role of angiotensin II in hypertension and end-organ damage Int. J. Clin. Pract. Suppl. 111 2000 4 8
141. L.G. Navar, L.M. Harrison-Bernard, A. Nishiyama, and H. Kobori Regulation of intrarenal angiotensin II in hypertension Hypertension 39 2002 316 322
142. L. Barlucchi, A. Leri, D.E. Dostal, F. Fiordaliso, H. Tada, and T.H. Hintze Canine ventricular myocytes posses a renin-angiotensin system that is upregulated with heart failure Circ. Res. 88 2001 298 304
143. P.S. Leung, and P.O. Carlsson Tissue renin-angiotensin system: its expression, localization, regulation and potential role in the pancreas J. Mol. Endocrinol. 26 2001 155 164
144. G.H. Goossens, E.E. Blaak, and M.A. van Baak Possible involvement of the adipose renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders Obes. Rev. 4 2003 43 55
145. P.S. Leung, M.L. Fung, and M.S. Tam Renin-angiotensin system in the carotid body Int. J. Biochem. Cell Biol. 35 2003 847 854
146. J.W. Wright, and J.W. Harding The brain angiotensin system and extra cellular matrix molecules in neural plasticity, learning, and memory Prog. Neurobiol. 72 2004 263 293
147. P.S. Leung The peptide hormone angiotensin II: its new functions in tissues and organs Curr. Protein Pept. Sci. 5 2004 267 273
148. P.S. Leung, and P.O. Carlsson Pancreatic islet renin angiotensin system: its novel roles in islet function and in diabetes mellitus Pancreas 30 2005 293 298
149. K.M. Baker, M.I. Chernin, T. Schreiber, S. Snaghi, S. Haiderzaidi, and G.W. Booz Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy Regul. Pept. 120 2004 5 13
150. K. Shan, K. Kurrelmeyer, Y. Seta, F. Wang, Z. Dibbs, A. Deswal, D. Lee-Jackson, and D.L. Mann The role of cytokines in disease progression in heart failure Curr. Opin. Cardiol. 12 1997 318 323
151. R.M. Carey, and H.M. Siragy Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation Endocr. Rev. 24 2003 261 271
152. K. Sekiguchi, X. Li, M. Coker, M. Flesch, P.M. Barger, and N. Sivasubramanian Cross-regulation between the renin-angiotensin system and inflammatory mediators in cardiac hypertrophy and failure Cardiovasc. Res. 63 2004 433 442
153. S. Rosenkranz TGF-beta l and angiotensin networking in cardiac remodeling Cardiovasc. Res. 63 2004 423 432
154. B.I. Levy How to explain the differences between renin angiotensin system modulators Am. J. Hypertens. 18 2005 134 141
155. U.M. Steckelings, and E. Kaschina Unger T. The AT2 receptor - a matter of love and hate Peptides 26 2005 1401 1409
156. J.M. Pfeffer, M.A. Pfeffer, and E. Braunwald Hemodynamic benefits and prolonged survival with long-term captopril therapy in rats with myocardial infarction and heart failure Circulation 75 1987 I149 I155
157. M.A. Pfeffer, G.A. Lamas, D.E. Vaughan, A.F. Parisi, and E. Braunwald Effect of captopril on progressive ventricular dilation after anterior myocardial infarction N. Engl. J. Med. 319 1998 80 86
158. Unlisted authors. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group N. Engl. J. Med. 316 1987 1429 1435
159. M.A. Pfeffer, E. Braunwald, L.A. Moye, L. Basta, E.J. Brown Jr., and T.E. Cuddy Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The Save Investigators N. Engl. J. Med. 327 1992 69 77
160. Unlisted authors. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators N. Engl. J. Med. 327 1992 685 691
161. E.O. Weinberg, F.J. Schoen, D. George, Y. Kagaya, P.S. Douglas, and S.E. Litwinn Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis Circulation 90 1994 1410 1422
162. J.J. McMurray, and M.A. Pfeffer Heart failure Lancet 365 2005 1877 1889
163. J.M. Pfeffer, M.A. Pfeffer, I. Mirsky, and E. Braunwald Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat Proc. Natl. Acad. Sci. USA 79 1982 3310 3314
164. X. Zhang, D.E. Dostal, K. Reiss, W. Cheng, J. Kajstura, and P. Li Identification and activation of autocrine renin-angiotensin system in adult ventricular myocytes Am. J. Physiol. 269 1995 H1791 H1802
165. A. Leri, Y. Liu, B. Li, F. Fiordaliso, A. Malhotra, and R. Latini Upregulation of AT1 and AT2 receptors in postinfarcted hypertrophied myocytes and stretch-mediated apoptotic cell death Am. J. Pathol. 156 2000 1663 1672
166. J. Sadoshima, Y. Xu, H.S. Slayter, and S. Izumo Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro Cell 75 1993 977 984
167. A. Leri, P.P. Claudio, Q. Li, X. Wang, K. Reiss, and S. Wang Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell J. Clin. Invest. 101 1998 1326 1342
168. W. Cheng, B. Li, J. Kajstura, P. Li, M.S. Wolin, E.H. Sonnenblick, T.H. Hintze, G. Olivetti, and P. Anversa Stretch-induced programmed myocyte cell death J. Clin. Invest. 96 1995 2247 2259
169. E. Cigola, J. Kajstura, B. Li, L.G. Meggs, and P. Anversa Angiotensin II activates programmed myocyte cell death in vitro Exp. Cell Res. 231 1997 363 371
170. J. Kajstura, E. Cigola, A. Malhotra, P. Li, W. Cheng, and L.G. Meggs Angiotensin II induces apoptosis of adult ventricular myocytes in vitro J. Mol. Cell. Cardiol. 29 1997 859 870
171. A.M. Capponi Distribution and signal transduction of angiotensin II AT1 and AT2 receptors Blood Press. Suppl. 2 1996 41 46
172. H. El-Adawi, L. Deng, A. Tramontano, S. Smith, E. Mascareno, and K. Ganguly The functional role of the JAK-STAT pathway in post-infarction remodeling Cardiovasc. Res. 57 2003 129 138
173. M. Flesch, A. Hoper, L. Dell'Italia, K. Evans, R. Bond, and R. Peshock Activation and functional significance of the rennin-angiotensin system in mice with cardiac restricted overexpression of tumor necrosis factor Circulation 108 2003 598 604
174. B. Ding, J. Abe, H. Wei, Q. Huang, R.A. Walsh, and C.A. Molina Functional role of phosphodiesterase 3 in cardiomyocyte apoptosis: implication in heart failure Circulation 111 2005 2469 2476
175. P. Pierzchalski, K. Reiss, W. Cheng, C. Cirielli, J. Kajstura, and J.A. Nitahara p53 induces myocyte apoptosis via the activation of the renin-angiotensin system Exp. Cell Res. 235 1997 57 65
176. A. Leri, F. Fiordaliso, M. Setoguchi, F. Limana, N.H. Bishopric, and J. Kajstura Inhibition of p53 function prevents rennin-angiotensin system activation and stretch-mediated myocyte apoptosis Am. J. Pathol. 157 2000 843 857
177. Q. Li, B. Li, X. Wang, A. Leri, K.P. Jana, and Y. Liu Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy J. Clin. Invest. 100 1997 1991 1999
178. B. Li, M. Setoguchi, X. Wang, A.M. Andreoli, A. Leri, and A. Malhotra Insulin-like growth factor-1 attenuates the detrimental impact of nonocclusive coronary artery constriction on the heart Circ. Res. 84 1999 1007 1019
179. K. Yamashita, J. Kajstura, D.J. Disher, B.J. Wasserlauf, N. Bishopric, and P. Anversa Reperfusion-activated Akt kinase prevents apoptosis in transgenic mouse hearts overexpressing insulin-like growth factor-1 Circ. Res. 88 2001 609 614
180. M. Ashcroft, Y. Taya, and K.H. Vousden Stress signals utilize multiple pathways to stabilize p53 Mol. Cell. Biol. 2000 3224 3233
181. Y. Haupt p53 regulation: a family affair Cell Cycle 3 2004 884 885
182. L. Chen, H. Yin, B. Farooqi, S. Sebti, A.D. Hamilton, and J. Chen p53 alpha-Helix mimetics antagonize p53/MDM2 interaction and activate p53 Mol. Cancer Ther. 4 2005 1019 1025
183. J.M. Stommel, and G.M. Wahl A new twist in the feedback loop: stress-activated Mdm2 destabilization is required for p53 activation Cell Cycle 4 2005 411 417
184. K.H. Vousden, and C. Prives p53 and prognosis: new insights and further complexity Cell 120 2005 7 10
185. A. Leri, Y. Liu, X. Wang, A. Malhotra, L.G. Meggs, and J. Kajstura Overexpression of insulin-like growth factor-1 attenuates the myocyte renin-angiotensin system in transgenic mice Circ. Res. 84 1999 752 762
186. S.M. Factor, A. Borczuck, M.J. Charron, F.S. Fein, K.H. van Hoeven, and E.H. Sonnenblick Myocardial alteration in diabetes and hypertension Diabetes Res. Clin. Pract. 31 1996 S133 S142
187. D.S.H. Bell Heart failure: the frequent, forgotten, and often fatal complication of diabetes Diabetes Care 26 2003 2433 2437
188. Y. Lu, P.L. Herrera, Y. Guo, D. Sun, Z. Tang, and D. LeRoith Pancreatic-specific inactivation of IGF-1 gene causes enlarged pancreatic islets and significant resistance to diabetes Diabetes 53 2004 3131 3141
189. F. Fiordaliso, B. Li, R. Latini, E.H. Sonnenblick, P. Anversa, and A. Leri Myocyte death in streptozotocin-induced diabetes in rats is angiotensin II-dependent Lab. Invest. 80 2000 513 527
190. P. Shaw, J. Freeman, R. Bovey, and R. Iggo Regulation of specific DNA binding by p53: evidence for a role for O-glycosylation and charged residues at the carboxy-terminus Oncogene 12 1996 921 930
191. K. Vosseler, K. Sakabe, L. Wells, and G.W. Hart Diverse regulation of protein function by O-GlcNAc: a nuclear and cytoplasmic carbohydrate post-translational modification Curr. Opin. Chem. Biol. 6 2002 851 857
192. K. Kamemura, B.K. Hayes, F.I. Comer, and G.W. Hart Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins J. Biol. Chem. 277 2002 19229 19235
193. W.A. Lubas, D.W. Frank, M. Krause, and J.A. Hannover O-Linked GlcNAc transferase is a conserved nucleocytoplasmic protein containing tetratricopeptide repeats J. Biol. Chem. 272 1997 9316 9324
194. L. Wells, S.A. Whelan, and G.W. Hart O-GlcNAc: a regulatory post-translational modification Biochem. Biophys. Res. Commun. 302 2003 435 441
195. K. Vosseler, L. Wells, M.D. Lane, and G.W. Hart Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes Proc. Natl. Acad. Sci. USA 99 2002 5313 5318
196. K.J. Davies Oxidative stress: the paradox of aerobic life Biochem. Soc. Symp. 61 1995 1 31
197. V.B. Djordevic Free radicals in cell biology Int. Rev. Cytol. 237 2004 57 89
198. D.E. Heck, V.E. Kagan, A.A. Shvedova, and J.D. Laskin An epigrammatic (abridged) recounting of the myriad tales of astonishing deeds and dire consequences pertaining to nitric oxide and ROS in mitochondria with an ancillary missive concerning the origin of apoptosis Toxicology 208 2005 259 271
199. E. Cadenas, and K.J. Davies Mitochondrial free radical generation, oxidative stress, and aging Free Radic. Biol. Med. 29 2000 222 230
200. I.Z. Nagy On the true role of oxygen free radicals in the living state, aging, and degenerative disorders Ann. N. Y. Acad. Sci. 928 2001 187 199
201. M.F. Beal Oxidatively modified proteins in aging and disease Free Radic. Biol. Med. 32 2002 797 803
202. 10 in mitochondrial respiratory chain and oxygen-derived free radical generation in cardiac cells Mol. Aspects Med. 18 1997 S41 S50
203. G. Cecchini Function and structure of complex II of the respiratory chain Annu. Rev. Biochem. 72 2003 77 109
204. B.D. Fink, K.J. Reszka, J.A. Herlein, M.M. Mathahs, and W.I. Sivitz Respiratory uncoupling by UCP1 and UCP2 and superoxide generation in endothelial cell mitochondria Am. J. Physiol. Endocrinol. Metab. 288 2005 E71 E79
205. 2+ handling Adv. Exp. Med. Biol. 513 2002 183 196
206. J. Jacobson, and M.R. Duchen Interplay between mitochondria and cellular calcium signalling Mol. Cell. Biochem. 2004 209 218 (256-257)
207. I.I. Kruman, and M.P. Mattson Pivotal role of mitochondrial calcium uptake in neural cell apoptosis and necrosis J. Neurochem. 72 1999 529 540
208. A.A. Starkov, C. Chinopoulos, and G. Fiskum Mitochondrial calcium and oxidative stress as mediators of ischemic brain injury Cell Calcium 36 2004 257 264
209. A.J. Kowaltowski, R.F. Castilho, and A.E. Vercesi Opening of the
210. G. Vendemiale, I. Grattagliano, and E. Altomare An update on the role of free radicals and antioxidant defense in human disease Int. J. Clin. Lab. Res. 29 1999 49 55
211. D.J. Betteridge What is oxidative stress? Metabolism 49 2000 3 8
212. + effects on mitochondrial respiration and oxidative phosphorylation in diabetic hearts Exp. Biol. Med. 226 2001 543 551
213. R.G. Hansford, and D. Zorov Role of mitochondrial calcium transport in the control of substrate oxidation Mol. Cell. Biochem. 184 1998 359 369
214. G. Davi, A. Falco, and C. Patrono Lipid peroxidation in diabetes mellitus Antioxid. Redox Signal. 7 2005 256 268
215. P. Anversa, M. Rota, K. Urbanek, T. Hosoda, E.H. Sonnenblick, and A. Leri Myocardial aging: a stem cell problem Basic Cardiovasc Res. 100 2005 482 493
216. P. Anversa, and G. Olivetti Cellular basis of physiological and pathological myocardial growth. In Handbook of physiology, section 2: the cardiovascular system: the heart, Volume 1 2002 Oxford University Press New York 75 144
217. P. Anversa, Z. Zhang, P. Li, and J.M. Capasso Chronic coronary artery constriction leads to moderate myocyte loss and left ventricular dysfunction and failure in rats J. Clin. Invest. 89 1992 618 629
218. P. Anversa, T. Palackal, E.H. Sonnenblick, G. Olivetti, L.G. Meggs, and J.M. Capasso Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart Circ. Res. 67 1990 871 885
219. C.A. Beltrami, N. Finato, M. Rocco, G.A. Feruglio, C. Puricelli, and E. Cigola Structural basis of end-stage failure in ischemic cardiomyopathy in humans Circulation 89 1994 151 163
220. C.A. Beltrami, N. Finato, M. Rocco, G.A. Feruglio, C. Puricelli, and E. Cigola The cellular basis of dilated cardiomyopathy in humans J. Mol. Cell. Cardiol. 27 1995 291 305
221. D. Wencker, M. Chandra, K. Nguyen, W. Miao, S. Garantziotis, and S.M. Factor A mechanistic role for cardiac myocyte apoptosis in heart failure J. Clin. Invest. 111 2003 1497 1504
222. G. Olivetti, R. Ricci, C. Lagrasta, E. Maniga, E.H. Sonnenblick, and P. Anversa Cellular basis of wall remodeling in long-term pressure overload-induced right ventricular hypertrophy in rats Circ. Res. 63 1988 648 657
223. G. Olivetti, J.M. Capasso, E.H. Sonnenblick, and P. Anversa Side-to-side slippage of myocytes participates in ventricular remodeling acutely after myocardial infarction in rats Circ. Res. 67 1990 23 34